Bone Mineral Density and Turnover in Children With Attention-Deficit Hyperactivity Disorder Receiving Methylphenidate

Abstract

Attention-deficit hyperactivity disorder (ADHD) is the most common behavior disorder among children; methylphenidate is a drug frequently prescribed for the control of its symptoms. One of the potential side effects of methylphenidate that concerns parents is its impact on the growth of children, since the mechanism by which methylphenidate might influence growth is not known. As linear growth is associated with an increase in bone mineral density and turnover, this study was undertaken to evaluate bone mineral density by dual photon absorptiometry and bone turnover by measuring serum bone-specific alkaline phosphatase and the urinary deoxypyridinoline excretion rate in children treated with methylphenidate for 1 to 2 years as compared to a control group. There were no significant differences in bone mineral density at either the lumbar spine or femoral neck in the study group (0.662 ± 0.04 and 0.735 ± 0.07 g/cm², respectively) as compared to the controls (0.675 ± 0.05 g/cm2 and 0.734 ± 0.07 g/cm2, respectively). Furthermore, there were no significant differences in serum bone-specific alkaline phosphatase in the study group (58 ± 22 U/L) as compared to the control children (71 ± 34 U/L) or in urinary deoxypyridinoline in the study group (34 ± 38 nM/mM), as compared to the control group (27 ± 12 nM/mM). In conclusion, our data do not support a significant effect of methylphenidate on bone mineral density turnover in children when used for 1 to 2 years. (J Child Neurol 2000;15:436-439).

Get full access to this article

View all access options for this article.

References

Baumgaertel A. , Wolraich ML : Practice guideline for the diagnosis and management of attention deficit hyperactivity disorder. Ambulatory Child Health 1998;4:45-58.

Hill P. : Attention deficit hyperactivity disorder, Arch Dis Child 1998; 79:381-385.

Ala-Houhala M. , Korpela R. , Koivikko M. , et al: Long term anticonvulsant therapy and vitamin D mechanism in ambulatory pubertal children. Neuropediatrics 1986;17:212-216.

Akin R. , Ukuten V. , Sarici U. , et al: Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 1998; 19:129-131.

Henderson R. : Bone density and other possible predictors of fracture risk in children and adolescents with spastic quadriplegia. Dev Med Child Neurol 1997;39:224-227.

Price CP : Multiple forms of human serum alkaline phosphatase: Detection and quantitation . Ann Clin Biochem 1993;30:355-372.

Price CP , Thompson PW : The role of biochemical tests in the screening and monitoring of osteoporosis . Ann Clin Biochem 1995;32:244-260.

Seyedin SM , Rosen DM : Matrix protein of the skeleton. Curr Opin Cell Biol 1990-12:914-919.

Delmas PD , Gineyts E. , Bertholin A. , et al: Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 1993 ;8:643-648.

10.

American Psychiatric Association : Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, American Psychiatric Association , 1994.

11.

Delmas PD : Biochemical markers of bone turnover. JBone Miner Res 1993;8(Suppl):S549-S555.

12.

Robins SP , Stewart P. , Astbury C. , Bird HA : Measurement of the cross-linking compound, pyridinoline in urine as an index of collagen degradation. Ann Rheum Dis 1986 ;45:969-973.

13.

Demers LM , Kleerekoper M. : Recent advances in biochemical markers of bone turnover, editorial . Clin Chem 1994;40:1994-1995.

14.

Stevenson RD , Wolraich ML : Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. Pediatr Clin North Am 1989;36:1183-1198.

15.

Safer D. , Allen R. , Barr F. : Depression of growth in hyperactive children on stimulant drugs. N Engl J Med 1972;287:217.

16.

Roche AF , Lipman RS , Overall JE , Hung W. : The effects of stimulant medications on the growth of hyperkinetic children . Pediatrics 1979;63:847-850.

17.

Schultz FR , Hayford JT , Wolraich ML , et al: Methylphenidate treatment of hyperactive children: Effects on the hypothalamic-pituitary-somatomedin axis. Pediatrics 1982;70:987-992.

18.

Kalachnik JF , Sprague RL , Sleator EK : Effect of methylphenidate hydrochloride on stature of hyperactive children. Dev Med Child Neurol 1982;24:586-595.

19.

Mattes JA , Gittelman R. : Growth of hyperactive children on maintenance regimen of methylphenidate . Arch Gen Psychiatry 1983; 40:317-321.

20.

Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder. Pediatrics 1987;80:758.

21.

Kilgore BS , Dickinson LC , Burnett CR , et al: Alternations in cartilage metabolism by neurostimulant drugs . J Pediatr 1973;94: 542-548.

22.

Conard CJ , Charles WS , Joseph ML : Clinical use of bone densiometry. N Engl J Med 1991;324:1105-1109.

23.

Lang P. , Steiger P. , Faulkner K. , et al: Osteoporosis: Current techniques and recent developments in quantitative bone densiometry. Radiol Clin North Am 1991;29:49-76.

24.

Tsukahara H. , Suto M. , Urrezak M. : Measurement of lumbar spinal bone mineral density in preterm infants by dual-energy x-ray absorptiometry. Biol Neonate 1993;64:96-103.

25.

Onse S. , Mimaki T. , Seino Y. , et al: Delayed bone development in epileptic children assessed by microdensitometer . Dev Pharmacol Ther 1988;11:24-31.

26.

Nishiyama S. , Kuwakara T. , Matsuda I: Decreased bone density in severely handicapped children and adults, with reference to the influence of limited morbidity and anticonvulsant medication. Eur J Pediatr 1988;144:457-463.